REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ELIXIR PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ELIXIR PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

ELIXIR PHARMA Kft. is an enterprise located in Hungary, with the main office in Baja. The company operates in the Pharmacies and Drug Stores sector. It was established on September 26, 2007. There are currently 9 (2024) people employed by ELIXIR PHARMA Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 6.87% in 2024. A negative growth of 2.07% was recorded in its total assets. In 2024, ELIXIR PHARMA Kft.’s net profit margin increased by 0.4%.

Headquarters
Kaszas utca 15. 1.
Baja; Bacs-Kiskun; Postal Code: 6503

Contact Details: Purchase the ELIXIR PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the ELIXIR PHARMA Kft. report to view the information.
Registered Capital:
Purchase the ELIXIR PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the ELIXIR PHARMA Kft. report to view the information.
Incorporation Date:
September 26, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after ELIXIR PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.87%▲
Total operating revenue
6.68%▲
Operating profit (EBIT)
23.61%▲
EBITDA
16.74%▲
Net Profit (Loss) for the Period
23.23%▲
Total Assets
-2.07%▼
Total Equity
11.27%▲
Operating Profit Margin (ROS)
0.46%▲
Net Profit Margin
0.4%▲
Return on Equity (ROE)
5.21%▲
Quick Ratio
0.12%▲
Cash Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo